BioCentury
ARTICLE | Company News

Asahi Kasei Pharma, Vernalis deal

March 31, 2014 7:00 AM UTC

Vernalis will receive a £300,000 ($494,820) milestone payment under a 2013 deal with Asahi to use Vernalis' fragment and structure-based drug discovery platform to discover low molecular weight compou...